{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:26:22Z","timestamp":1790796382064,"version":"4.1.0"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:00:00Z","timestamp":1769644800000},"content-version":"vor","delay-in-days":22,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-34116-x","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T13:27:09Z","timestamp":1767792429000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["In-silico screening of marine fungal metabolites identifies potential FtsZ inhibitors against MDR-tuberculosis through docking and molecular dynamics analysis"],"prefix":"10.1038","volume":"16","author":[{"given":"Meghana","family":"S R","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yogesh","family":"H S","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sibghatullah Muhammad Ali","family":"Sangi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anitha","family":"K N","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadik","family":"Shaik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sreeharsha","family":"Nagaraja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Girish","family":"Meravanige","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Monirul","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavan Kumar","family":"Sreenivasalu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rashed M.","family":"Almuqbil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahzad","family":"Chohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bipindra","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shankar","family":"Thapa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1914-973X","authenticated-orcid":false,"given":"Ayomide Victor","family":"Atoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,7]]},"reference":[{"key":"34116_CR1","doi-asserted-by":"publisher","first-page":"113732","DOI":"10.1016\/j.ejmech.2021.113732","volume":"224","author":"G Cazzaniga","year":"2021","unstructured":"Cazzaniga, G. et al. Natural products against key Mycobacterium tuberculosis enzymatic targets: emerging opportunities for drug discovery. Eur. J. Med. Chem. 224, 113732 (2021).","journal-title":"Eur. J. Med. Chem."},{"key":"34116_CR2","unstructured":"World Health Organization. Global Tuberculosis Report 2024. Geneva: WHO. Licence: CC BY-NC-SA 3.0 IGO. Glob. Tuberc. Rep. 68 (2024). (2024)."},{"key":"34116_CR3","doi-asserted-by":"publisher","first-page":"107325","DOI":"10.1016\/j.ijid.2024.107325","volume":"150","author":"D Goletti","year":"2025","unstructured":"Goletti, D., Meintjes, G., Andrade, B. B., Zumla, A. & Shan Lee, S. Insights from the 2024 WHO global tuberculosis Report \u2013 More comprehensive Action, Innovation, and investments required for achieving WHO end TB goals. Int. J. Infect. Dis. 150, 107325 (2025).","journal-title":"Int. J. Infect. Dis."},{"key":"34116_CR4","doi-asserted-by":"publisher","first-page":"119101","DOI":"10.1016\/j.molliq.2022.119101","volume":"358","author":"R Singh","year":"2022","unstructured":"Singh, R., Kumar, S., Bhardwaj, V. K. & Purohit, R. Screening and reckoning of potential therapeutic agents against DprE1 protein of Mycobacterium tuberculosis. J. Mol. Liq. 358, 119101 (2022).","journal-title":"J. Mol. Liq"},{"key":"34116_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0075245","volume":"8","author":"TR Ioerger","year":"2013","unstructured":"Ioerger, T. R. et al. Identification of new drug targets and resistance mechanisms in Mycobacterium tuberculosis. PLoS One. 8, 1\u201313 (2013).","journal-title":"PLoS One"},{"key":"34116_CR6","doi-asserted-by":"crossref","unstructured":"Mi, J., Gong, W. & Wu, X. Advances in Key Drug Target Identification and New Drug Development for Tuberculosis. Biomed Res. Int. 1\u201323 (2022).","DOI":"10.1155\/2022\/5099312"},{"key":"34116_CR7","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.coph.2006.06.004","volume":"6","author":"K Mdluli","year":"2006","unstructured":"Mdluli, K. & Spigelman, M. Novel targets for tuberculosis drug discovery. Curr. Opin. Pharmacol. 6, 459\u2013467 (2006).","journal-title":"Curr. Opin. Pharmacol."},{"key":"34116_CR8","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1021\/jm050920y","volume":"49","author":"Q Huang","year":"2006","unstructured":"Huang, Q. et al. Targeting FtsZ for antituberculosis drug discovery: noncytotoxic taxanes as novel antituberculosis agents. J. Med. Chem. 49, 463\u2013466 (2006).","journal-title":"J. Med. Chem."},{"key":"34116_CR9","doi-asserted-by":"publisher","first-page":"101920","DOI":"10.1016\/j.tube.2020.101920","volume":"121","author":"OI Akinpelu","year":"2020","unstructured":"Akinpelu, O. I., Lawal, M. M., Kumalo, H. M. & Mhlongo, N. N. Drug repurposing: fusidic acid as a potential inhibitor of M. tuberculosis FtsZ polymerization \u2013 Insight from DFT calculations, molecular Docking and molecular dynamics simulations. Tuberculosis 121, 101920 (2020).","journal-title":"Tuberculosis"},{"key":"34116_CR10","first-page":"310","volume":"20","author":"M Rahman","year":"2020","unstructured":"Rahman, M., Wang, P., Wang, N. & Chen, Y. A key bacterial cytoskeletal cell division protein FtsZ as a novel therapeutic antibacterial drug target. BJBMS 20, 310\u2013318 (2020).","journal-title":"BJBMS"},{"key":"34116_CR11","doi-asserted-by":"publisher","first-page":"527","DOI":"10.2174\/156802607780059790","volume":"7","author":"Q Huang","year":"2007","unstructured":"Huang, Q., Tonge, P. J., Slayden, R. A., Kirikae, T. & Ojima, I. FtsZ: A novel target for tuberculosis drug discovery. Curr. Top. Med. Chem. 7, 527\u2013543 (2007).","journal-title":"Curr. Top. Med. Chem."},{"key":"34116_CR12","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.1016\/j.apsb.2023.01.022","volume":"13","author":"H Zhang","year":"2023","unstructured":"Zhang, H., Chen, Y., Zhang, Y. & Qiao, L. Identification of anti- Mycobacterium tuberculosis agents targeting the interaction of bacterial division proteins FtsZ and SepFe. Acta Pharm. Sin B. 13, 2056\u20132070 (2023).","journal-title":"Acta Pharm. Sin B"},{"key":"34116_CR13","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.4155\/fmc.10.220","volume":"2","author":"K Kumar","year":"2010","unstructured":"Kumar, K. et al. Discovery of anti-TB agents that target the cell-division protein FtsZ. Future Med. Chem. 2, 1305\u20131323 (2010).","journal-title":"Future Med. Chem."},{"key":"34116_CR14","doi-asserted-by":"publisher","first-page":"105279","DOI":"10.1016\/j.micinf.2023.105279","volume":"26","author":"R Singh","year":"2024","unstructured":"Singh, R., Manna, S., Nandanwar, H. & Purohit, R. Bioactives from medicinal herb against bedaquiline resistant tuberculosis: removing the dark clouds from the horizon. Microbes Infect. 26, 105279 (2024).","journal-title":"Microbes Infect."},{"key":"34116_CR15","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1007\/s00203-024-04233-8","volume":"207","author":"S Patel","year":"2025","unstructured":"Patel, S. et al. Diversity of secondary metabolites from marine streptomyces with potential anti-tubercular activity: a review. Arch. Microbiol. 207, 64 (2025).","journal-title":"Arch. Microbiol."},{"key":"34116_CR16","doi-asserted-by":"publisher","first-page":"107699","DOI":"10.1016\/j.bioorg.2024.107699","volume":"151","author":"X Peng","year":"2024","unstructured":"Peng, X., Zeng, Z., Hassan, S. & Xue, Y. The potential of marine natural products: recent advances in the discovery of Anti-Tuberculosis agents. Bioorg. Chem. 151, 107699 (2024).","journal-title":"Bioorg. Chem."},{"key":"34116_CR17","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1002\/ardp.201600128","volume":"349","author":"G Daletos","year":"2016","unstructured":"Daletos, G., Ancheeva, E., Chaidir, C., Kalscheuer, R. & Proksch, P. Antimycobacterial metabolites from marine invertebrates. Arch. Pharm. (Weinheim). 349, 763\u2013773 (2016).","journal-title":"Arch. Pharm. (Weinheim)"},{"key":"34116_CR18","doi-asserted-by":"crossref","unstructured":"Hafez Ghoran, S., Taktaz, F., Ayatollahi, S. A. & Kijjoa, A. Anthraquinones and their analogues from Marine-Derived fungi: chemistry and biological activities. Marine Drugs 20, 1-69 (2022).","DOI":"10.3390\/md20080474"},{"key":"34116_CR19","doi-asserted-by":"publisher","first-page":"e12406","DOI":"10.1016\/j.heliyon.2022.e12406","volume":"8","author":"KI Tapfuma","year":"2022","unstructured":"Tapfuma, K. I. et al. Antimycobacterial activity and molecular Docking of methanolic extracts and compounds of marine fungi from Saldanha and false Bays, South Africa. Heliyon 8, e12406 (2022).","journal-title":"Heliyon"},{"key":"34116_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/molecules26237328","volume":"26","author":"R Villanueva-Silva","year":"2021","unstructured":"Villanueva-Silva, R. et al. Chemical diversity and antimicrobial potential of cultivable fungi from deep-sea sediments of the Gulf of Mexico. Molecules 26, 1\u201316 (2021).","journal-title":"Molecules"},{"key":"34116_CR21","first-page":"1","volume":"21","author":"J Aghajani","year":"2022","unstructured":"Aghajani, J. & Farnia, P. Molecular dynamic simulations and molecular Docking as a potential way for designed new inhibitor drug without resistance. Tanaffos 21, 1\u201314 (2022).","journal-title":"Tanaffos"},{"key":"34116_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/fsn3.70857","volume":"13","author":"P Kamaria","year":"2025","unstructured":"Kamaria, P. et al. Evaluation of Quercus infectoria phytoconstituents against oral cancer: network Pharmacology, Docking Simulation, and in vitro cytotoxicity assay. Food Sci. Nutr. 13, 1\u201323 (2025).","journal-title":"Food Sci. Nutr."},{"key":"34116_CR23","doi-asserted-by":"publisher","first-page":"D509","DOI":"10.1093\/nar\/gkaa763","volume":"49","author":"C Lyu","year":"2021","unstructured":"Lyu, C. et al. CMNPD: A comprehensive marine natural products database towards facilitating drug discovery from the ocean. Nucleic Acids Res. 49, D509\u2013D515 (2021).","journal-title":"Nucleic Acids Res."},{"key":"34116_CR24","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1093\/nar\/gkae1063","volume":"53","author":"V Chandrasekhar","year":"2025","unstructured":"Chandrasekhar, V. et al. COCONUT 2. 0 : a comprehensive overhaul and curation of the collection of open natural products database. Nucleic Acids Res. 53, 634\u2013643 (2025).","journal-title":"Nucleic Acids Res."},{"key":"34116_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-025-12523-4","volume":"15","author":"F Shabbir","year":"2025","unstructured":"Shabbir, F. et al. Computer-aided screening of marine fungal metabolites as potential inhibitors of new Delhi metallo-beta-lactamase-1. Sci. Rep. 15, 1\u201324 (2025).","journal-title":"Sci. Rep."},{"key":"34116_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmicb.2013.00065","volume":"4","author":"WK Mousa","year":"2013","unstructured":"Mousa, W. K. & Raizada, M. N. The diversity of anti-microbial secondary metabolites produced by fungal endophytes: an interdisciplinary perspective. Front. Microbiol. 4, 1\u201318 (2013).","journal-title":"Front. Microbiol."},{"key":"34116_CR27","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/ja.2017.52","volume":"70","author":"KY He","year":"2017","unstructured":"He, K. Y. et al. New chlorinated Xanthone and anthraquinone produced by a mangrove-derived fungus penicillium citrinum HL-5126. J. Antibiot. (Tokyo). 70, 823\u2013827 (2017).","journal-title":"J. Antibiot. (Tokyo)"},{"key":"34116_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/md17100563","volume":"17","author":"XD Li","year":"2019","unstructured":"Li, X. D., Li, X. M., Yin, X. L., Li, X. & Wang, B. G. Antimicrobial sesquiterpenoid derivatives and monoterpenoids from the deep-sea sediment-derived fungus Aspergillus versicolor SD-330. Mar. Drugs. 17, 1\u201312 (2019).","journal-title":"Mar. Drugs"},{"key":"34116_CR29","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1021\/np300103w","volume":"75","author":"KL Yang","year":"2012","unstructured":"Yang, K. L. et al. Antibacterial anthraquinone derivatives from a sea anemone-derived fungus Nigrospora Sp. J. Nat. Prod. 75, 935\u2013941 (2012).","journal-title":"J. Nat. Prod."},{"key":"34116_CR30","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1021\/np060552g","volume":"70","author":"PN Hung","year":"2007","unstructured":"Hung, P. N. et al. Dehydroxychlorofusarielin B, an antibacterial polyoxygenated decalin derivative from the marine-derived fungus Aspergillus Sp. J. Nat. Prod. 70, 1188\u20131190 (2007).","journal-title":"J. Nat. Prod."},{"key":"34116_CR31","doi-asserted-by":"publisher","first-page":"2699","DOI":"10.1021\/acs.jnatprod.5b00655","volume":"78","author":"W Guo","year":"2015","unstructured":"Guo, W. et al. Antibacterial polyketides from the Deep-Sea-Derived fungus penicillium sp. F23-2. J. Nat. Prod. 78, 2699\u20132703 (2015).","journal-title":"J. Nat. Prod."},{"key":"34116_CR32","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.phytol.2014.06.014","volume":"10","author":"N Khamthong","year":"2014","unstructured":"Khamthong, N., Rukachaisirikul, V., Phongpaichit, S., Preedanon, S. & Sakayaroj, J. An antibacterial cytochalasin derivative from the marine-derived fungus diaporthaceae sp. PSU-SP2\/4. Phytochem Lett. 10, 5\u20139 (2014).","journal-title":"Phytochem Lett."},{"key":"34116_CR33","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3390\/md18110553","volume":"18","author":"YH Li","year":"2020","unstructured":"Li, Y. H. et al. Antibacterial alkaloids and polyketide derivatives from the deep Sea-Derived fungus penicillium cyclopium SD-413. Mar. Drugs. 18, 5\u201312 (2020).","journal-title":"Mar. Drugs"},{"key":"34116_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/md15110348","volume":"15","author":"W Wang","year":"2017","unstructured":"Wang, W. et al. Cytotoxic and antibacterial compounds from the coral-derived fungus Aspergillus tritici SP2-8-1. Mar. Drugs. 15, 1\u201310 (2017).","journal-title":"Mar. Drugs"},{"key":"34116_CR35","doi-asserted-by":"crossref","unstructured":"Yu, G. et al. Cytotoxic tetrahydroxanthone dimers from the mangrove-associated fungus Aspergillus versicolor HDN1009. Mar. Drugs 16, 1\u20138 (2018).","DOI":"10.3390\/md16090335"},{"key":"34116_CR36","doi-asserted-by":"crossref","unstructured":"Thapa, S., Biradar, M. S., Banerjee, J. & Karati, D. In-silico approach for predicting the inhibitory effect of home remedies on severe acute respiratory syndrome Coronavirus-2 In-silico approach for predicting the inhibitory effect of home remedies on severe acute respiratory syndrome Coronavirus-2. Makar J. Sci 27, 194\u2013207 (2023).","DOI":"10.7454\/mss.v27i3.1609"},{"key":"34116_CR37","doi-asserted-by":"publisher","first-page":"106523","DOI":"10.1016\/j.jinf.2025.106523","volume":"91","author":"L Sonnenkalb","year":"2025","unstructured":"Sonnenkalb, L., Trubenov\u00e1, B., Regoes, R. R., Merker, M. & Niemann, S. The mutant selection window of Moxifloxacin and bedaquiline resistant Mycobacterium tuberculosis. J. Infect. 91, 106523 (2025).","journal-title":"J. Infect."},{"key":"34116_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40203-015-0014-1","volume":"3","author":"JA Shilpi","year":"2015","unstructured":"Shilpi, J. A. et al. Molecular Docking studies on InhA, MabA and PanK enzymes from Mycobacterium tuberculosis of ellagic acid derivatives from Ludwigia adscendens and Trewia nudiflora. Silico Pharmacol. 3, 1\u20137 (2015).","journal-title":"Silico Pharmacol."},{"key":"34116_CR39","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.jmb.2004.07.061","volume":"342","author":"AKW Leung","year":"2004","unstructured":"Leung, A. K. W. et al. Structure of Mycobacterium tuberculosis FtsZ reveals Unexpected, G Protein-like conformational switches. J. Mol. Biol. 342, 953\u2013970 (2004).","journal-title":"J. Mol. Biol."},{"key":"34116_CR40","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s44371-025-00128-9","volume":"2","author":"SPC Kurmi","year":"2025","unstructured":"Kurmi, S. P. C., Thapa, S. & Karati, D. Molecular Docking and Pharmacokinetic evaluations of curcumin-based scaffolds as MDM2-p53 inhibitors. Discov Chem. 2, 53 (2025).","journal-title":"Discov Chem."},{"key":"34116_CR41","doi-asserted-by":"publisher","first-page":"7206","DOI":"10.1039\/C7CP08010G","volume":"20","author":"Q Shao","year":"2018","unstructured":"Shao, Q. & Zhu, W. Assessing AMBER force fields for protein folding in an implicit solvent. Phys. Chem. Chem. Phys. 20, 7206\u20137216 (2018).","journal-title":"Phys. Chem. Chem. Phys."},{"key":"34116_CR42","doi-asserted-by":"crossref","unstructured":"Thapa, S., Nargund, S. L. & Biradar, M. S. Molecular Design and In-Silico Analysis of Trisubstituted Benzimidazole Derivatives as Ftsz Inhibitor. J. Chem. 1\u20139 (2023). (2023).","DOI":"10.1155\/2023\/9307613"},{"key":"34116_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0309797","volume":"19","author":"B Pandey","year":"2024","unstructured":"Pandey, B. et al. LC-MS profiling and cytotoxic activity of angiopteris Helferiana against HepG2 cell line: molecular insight to investigate anticancer agent. PLoS One. 19, 1\u201324 (2024).","journal-title":"PLoS One"},{"key":"34116_CR44","doi-asserted-by":"crossref","unstructured":"Laskowski R A, MacArthur M W, Moss D S, Thornton J M. PROCHECK - a program to check the stereochemical quality of protein structures. J. App. Cryst. 26, 283\u2013291 (1993).","DOI":"10.1107\/S0021889892009944"},{"key":"34116_CR45","doi-asserted-by":"publisher","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","volume":"61","author":"J Eberhardt","year":"2021","unstructured":"Eberhardt, J., Santos-Martins, D., F Tillack, A. & Forli, S. AutoDock Vina 1.2.0: new Docking Methods, expanded force Field, and python bindings. J. Chem. Inf. Model. 61, 3891\u20133898 (2021).","journal-title":"J. Chem. Inf. Model."},{"key":"34116_CR46","doi-asserted-by":"publisher","first-page":"186","DOI":"10.2174\/1386207319666161214112536","volume":"13","author":"HR Bhojwani","year":"2017","unstructured":"Bhojwani, H. R. & Joshi, U. J. Pharmacophore and Docking guided virtual screening study for discovery of type I inhibitors of VEGFR-2 kinase. Curr. Comput. Aided Drug Des. 13, 186\u2013207 (2017).","journal-title":"Curr. Comput. Aided Drug Des."},{"key":"34116_CR47","first-page":"1","volume":"38","author":"S Thapa","year":"2023","unstructured":"Thapa, S., Nargund, S. L., Biradar, M. S., Banerjee, J. & Karati, D. In-silico investigation and drug likeliness studies of benzimidazole congeners: the new face of innovation. Inf. Med. Unlocked. 38, 1\u201311 (2023).","journal-title":"Inf. Med. Unlocked"},{"key":"34116_CR48","first-page":"1","volume":"19","author":"MAAI Id","year":"2024","unstructured":"Id, M. A. A. I. et al. Benzothiazinone analogs as Anti- Mycobacterium tuberculosis DprE1 irreversible inhibitors: covalent docking, validation, and molecular dynamics simulations. PosOne 19, 1\u201324 (2024).","journal-title":"PosOne"},{"key":"34116_CR49","doi-asserted-by":"publisher","first-page":"100636","DOI":"10.1016\/j.prmcm.2025.100636","volume":"16","author":"S Thapa","year":"2025","unstructured":"Thapa, S. et al. LC-MS profiling and multi-target mechanistic insights of hibiscus rosa-sinensis in diabetes: network pharmacology, molecular docking, MD simulation, PCA, and in-vitro \u03b1-amylase Inhibition. Pharmacol. Res. - Mod. Chin. Med. 16, 100636 (2025).","journal-title":"Pharmacol. Res. - Mod. Chin. Med."},{"key":"34116_CR50","first-page":"1","volume":"0","author":"AR Zala","year":"2023","unstructured":"Zala, A. R. et al. Molecular modeling and biological investigation of novel s-triazine linked benzothiazole and coumarin hybrids as antimicrobial and antimycobacterial agents. J. Biomol. Struct. Dyn. 0, 1\u201312 (2023).","journal-title":"J. Biomol. Struct. Dyn."},{"key":"34116_CR51","doi-asserted-by":"publisher","unstructured":"H S, Y. et al. Polyphenol-based therapeutics for glioblastoma: validation from In-vitro cell viability assay and integrated onco-omics computational analysis. Naunyn Schmiedebergs Arch. Pharmacol (2025). https:\/\/doi.org\/10.1007\/s00210-025-04690-y","DOI":"10.1007\/s00210-025-04690-y"},{"key":"34116_CR52","first-page":"1","volume":"2","author":"R Kumar","year":"2025","unstructured":"Kumar, R. et al. Molecular docking, drug \u2013 likeness properties, and toxicity prediction of alkaloidal phytoconstituents of Piper longum against monoamine oxidase enzyme \u2013 A as an anti \u2013 depressive agent. Discov Chem. 2, 1\u201318 (2025).","journal-title":"Discov Chem."},{"key":"34116_CR53","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s13337-025-00933-x","volume":"3","author":"S Kiran","year":"2025","unstructured":"Kiran, S. et al. Integrated computational approach revealed the potential inhibitory effect of Xanthone derivatives against Marburg virus nucleocapsid. VirusDisease 3, 415\u2013427 (2025).","journal-title":"VirusDisease"},{"key":"34116_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fcimb.2021.730288","volume":"11","author":"PP Kushwaha","year":"2021","unstructured":"Kushwaha, P. P. et al. Identification of natural inhibitors against SARS-CoV-2 drugable targets using molecular Docking, molecular dynamics Simulation, and MM-PBSA approach. Front. Cell. Infect. Microbiol. 11, 1\u201317 (2021).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"34116_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13065-024-01182-7","volume":"18","author":"BS Alotaibi","year":"2024","unstructured":"Alotaibi, B. S. In Silico identification of phytochemical inhibitors for multidrug-resistant tuberculosis based on novel pharmacophore generation and molecular dynamics simulation studies. BMC Chem. 18, 1\u201312 (2024).","journal-title":"BMC Chem."},{"key":"34116_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/biomedicines11030793","volume":"11","author":"I Ali","year":"2023","unstructured":"Ali, I. et al. Identification of natural lead compounds against Hemagglutinin-Esterase surface glycoprotein in human coronaviruses investigated via MD Simulation, principal component Analysis, Cross-Correlation, H-Bond plot and MMGBSA. Biomedicines 11, 1\u201317 (2023).","journal-title":"Biomedicines"},{"key":"34116_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/11779322251365019","volume":"19","author":"P C","year":"2025","unstructured":"C, P. et al. Repurposing terfenadine and Domperidone for Inhibition of apoptotic gene association in colorectal cancer: A system Pharmacology approach integrated with molecular docking, MD simulations, and post-MD simulation analysis. Bioinform Biol. Insights. 19, 1\u201321 (2025).","journal-title":"Bioinform Biol. Insights"},{"key":"34116_CR58","doi-asserted-by":"publisher","first-page":"W422","DOI":"10.1093\/nar\/gkae236","volume":"52","author":"L Fu","year":"2024","unstructured":"Fu, L. et al. ADMETlab 3.0: an updated comprehensive online ADMET prediction platform enhanced with broader coverage, improved performance, API functionality and decision support. Nucleic Acids Res. 52, W422\u2013W431 (2024).","journal-title":"Nucleic Acids Res."},{"key":"34116_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1289\/EHP9341","volume":"130","author":"JVB Borba","year":"2022","unstructured":"Borba, J. V. B., Alves, V. M. & Braga, R. C. STopTox: an in Silico alternative to animal testing for acute systemic and topical toxicity. Environ. Health Perspect. 130, 1\u201312 (2022).","journal-title":"Environ. Health Perspect."},{"key":"34116_CR60","doi-asserted-by":"publisher","first-page":"W513","DOI":"10.1093\/nar\/gkae303","volume":"52","author":"P Banerjee","year":"2024","unstructured":"Banerjee, P., Kemmler, E., Dunkel, M. & Preissner, R. ProTox 3.0: a webserver for the prediction of toxicity of chemicals. Nucleic Acids Res. 52, W513\u2013W520 (2024).","journal-title":"Nucleic Acids Res."},{"key":"34116_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/md23070279","volume":"23","author":"M Azhari","year":"2025","unstructured":"Azhari, M., Merliani, N., Singgih, M., Arai, M. & Julianti, E. Insights into natural products from Marine-Derived fungi with antimycobacterial properties: opportunities and challenges. Mar. Drugs. 23, 1\u201349 (2025).","journal-title":"Mar. Drugs"},{"key":"34116_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/md21120616","volume":"21","author":"J Fu","year":"2023","unstructured":"Fu, J. et al. Marine-Fungi-Derived gliotoxin promotes autophagy to suppress mycobacteria tuberculosis infection in macrophage. Mar. Drugs. 21, 1\u201314 (2023).","journal-title":"Mar. Drugs"},{"key":"34116_CR63","doi-asserted-by":"publisher","first-page":"102354","DOI":"10.1016\/j.rechem.2025.102354","volume":"16","author":"R Bharti","year":"2025","unstructured":"Bharti, R., Mishra, S. & Pandey, A. Identification of natural FtsZ inhibitors through computational approaches to combat drug-resistant tuberculosis. Results Chem. 16, 102354 (2025).","journal-title":"Results Chem."},{"key":"34116_CR64","doi-asserted-by":"publisher","first-page":"103169","DOI":"10.1016\/j.bioorg.2019.103169","volume":"91","author":"S Tripathy","year":"2019","unstructured":"Tripathy, S. & Sahu, S. K. FtsZ inhibitors as a new genera of antibacterial agents. Bioorg. Chem. 91, 103169 (2019).","journal-title":"Bioorg. Chem."},{"key":"34116_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/microorganisms12081505","volume":"12","author":"AM Tovar-Nieto","year":"2024","unstructured":"Tovar-Nieto, A. M. et al. The repurposing of FDA-Approved drugs as FtsZ inhibitors against Mycobacterium tuberculosis: an in Silico and in vitro study. Microorganisms 12, 1\u201313 (2024).","journal-title":"Microorganisms"},{"key":"34116_CR66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/molecules27061907","volume":"27","author":"M Gurnani","year":"2022","unstructured":"Gurnani, M. et al. Inhibition of filamentous thermosensitive Mutant-Z protein in Bacillus subtilis by cyanobacterial bioactive compounds. Molecules 27, 1\u201321 (2022).","journal-title":"Molecules"},{"key":"34116_CR67","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1021\/acsinfecdis.4c01045","volume":"11","author":"P Sci\u00f2","year":"2025","unstructured":"Sci\u00f2, P. et al. Identification of a new FtsZ inhibitor by virtual Screening, mechanistic Insights, and Structure-Activity relationship analyses. ACS Infect. Dis. 11, 998\u20131007 (2025).","journal-title":"ACS Infect. Dis."},{"key":"34116_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-025-98835-x","volume":"15","author":"A Roy","year":"2025","unstructured":"Roy, A. & Anbarasu, A. Unveiling Berberine analogues as potential inhibitors of Escherichia coli FtsZ through machine learning molecular Docking and molecular dynamics approach. Sci. Rep. 15, 1\u201318 (2025).","journal-title":"Sci. Rep."},{"key":"34116_CR69","doi-asserted-by":"publisher","first-page":"35270","DOI":"10.1038\/s41598-025-18084-w","volume":"15","author":"PN Sonwane","year":"2025","unstructured":"Sonwane, P. N. & Kumbhare, M. R. Molecular Docking and pharmacokinetics of benzimidazole-based FtsZ inhibitors for tuberculosis. Sci. Rep. 15, 35270 (2025).","journal-title":"Sci. Rep."},{"key":"34116_CR70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmolb.2023.1087676","volume":"10","author":"D Vemula","year":"2023","unstructured":"Vemula, D., Maddi, D. R. & Bhandari, V. Homology modeling, virtual screening, molecular docking, and dynamics studies for discovering Staphylococcus epidermidis FtsZ inhibitors. Front. Mol. Biosci. 10, 1\u201324 (2023).","journal-title":"Front. Mol. Biosci."},{"key":"34116_CR71","doi-asserted-by":"publisher","first-page":"101213","DOI":"10.1016\/j.imu.2023.101213","volume":"38","author":"S Thapa","year":"2023","unstructured":"Thapa, S., Nargund, S. L., Biradar, M. S., Banerjee, J. & Karati, D. In-silico investigation and drug likeliness studies of benzimidazole congeners: the new face of innovation. Inf. Med. Unlocked. 38, 101213 (2023).","journal-title":"Inf. Med. Unlocked"},{"key":"34116_CR72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/app14219878","volume":"14","author":"S Saha","year":"2024","unstructured":"Saha, S. et al. Molecular dynamics Simulation, and quantum mechanics calculation based phytochemical screening of Croton Bonplandianum against breast cancer by targeting Estrogen Receptor-\u03b1 (ER\u03b1). Appl. Sci. 14, 1\u201322 (2024). Pharmacoinformatics.","journal-title":"Appl. Sci."},{"key":"34116_CR73","first-page":"e01745","volume":"21","author":"O Abchir","year":"2023","unstructured":"Abchir, O. et al. Exploration of cannabis constituents as potential candidates against diabetes mellitus disease using molecular docking, dynamics simulations and ADMET investigations. Sci. Afr. 21, e01745 (2023).","journal-title":"Sci. Afr."},{"key":"34116_CR74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0306973","volume":"19","author":"F Aghahosseini","year":"2024","unstructured":"Aghahosseini, F., Bayat, M., Sadeghian, Z., Gheidari, D. & Safari, F. Synthesis, molecular Docking study, MD simulation, ADMET, and drug likeness of new thiazolo[3,2-a]pyridine-6,8-dicarbonitrile derivatives as potential anti-diabetic agents. PLoS One. 19, 1\u201319 (2024).","journal-title":"PLoS One"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-34116-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-34116-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-34116-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T11:05:18Z","timestamp":1769684718000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-34116-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,7]]},"references-count":74,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["34116"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-34116-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,7]]},"assertion":[{"value":"6 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4030"}}